- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Anti-Aging
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
Radiesse gets FDA nod for facial aesthetics
San Mateo, Calif. - Newly approved Radiesse - billed by manufacturer BioForm Medical as the "next-generation" dermal filler - offers long-lasting correction of moderate-to-severe facial wrinkles and folds, the company says.
San Mateo, Calif. - Newly approved Radiesse - billed by manufacturer BioForm Medical as the "next-generation" dermal filler - offers long-lasting correction of moderate-to-severe facial wrinkles and folds, the company says.
The Food and Drug Administration approved Radiesse for that indication in late December, and also approved use of the filler for long-lasting correction of facial lipoatrophy in patients with HIV.
Radiesse is the first cosmetic filler with a proven 12-month benefit in multiple clinical studies, BioForm Medical President and CEO Steven L. Basta said in a prepared statement.
According to BioForm Medical:
